Loading
Everything OnCo dates to 1954: 11 entries, 6 landmarks, 2 approvals, 2 papers and 1 technology. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
11 dated entries in OnCo fall in 1954: 6 landmarks, 2 approvals, 2 papers and 1 technology.
Of those, 11 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Palliative treatment of chronic myelogenous leukaemia (Myleran tablets)
Lymphangiography and hysterosalpingography; selective hepatic intra-arterial imaging of hepatocellular carcinoma added in 2014
The publication year on key paper records.
ARMITAGE P, DOLL R. British Journal of Cancer.
Doll R, Hill AB. BMJ.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Small intestinal neuroendocrine tumours
Neuroendocrine tumours
Lung cancer (all types). The 1950 case-control studies were called artefacts, so a cohort was assembled before anybody was ill and followed to death.
Gallbladder cancer. Glenn and Hays describe en bloc liver-bed resection with lymphadenectomy.
Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4)
Brain metastases (secondary brain tumours). Chao and colleagues describe palliative irradiation of cerebral metastases.
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.